LIPOGEMS RAISES €12.5M ($13.2M) TO ACCELERATE THE EXPANSION IN KNEE OSTEOARTHRITIS

ATLANTA, Dec. 23, 2022 /PRNewswire/ -- Lipogems, a clinical stage- global medical technology company that utilizes autologous adipose tissue for t...

Related Keywords

Italy ,Italian ,Carl Llewellyn ,Stefano Buono ,Euronext Milan Stock Exchange ,Holding Company ,Company Under Italian ,Novartis ,Knee Osteoarthritis ,Lipogems United States About ,Business Model ,Venture Capital ,Advanced Accelerator Applications ,